As big pharma exits Nigeria, asthma patients face spiralling costs

Price of asthma inhalers has more than doubled amid scarcity and added costs after GSK exited Nigerian market in 2023.

Related Posts

Iran presidential election guide

admin Jun 27, 2024  0  4

What are the big issues that will decide the UK election?

admin Jul 1, 2024  0  4

How not to show solidarity with the Palestinian people

admin Jun 16, 2024  0  9

Comments

Name

Email

Comment

Post Comment